TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Genky DrugStores Co., Ltd. ( (JP:9267) ).
Genky DrugStores Co., Ltd. reported a 7.9% increase in net sales for the nine months ending March 20, 2025, compared to the same period the previous year. The company also saw a 9.4% rise in net income attributable to owners of the parent, reflecting strong operational performance. Despite a stock split implemented in June 2024, the company maintained its financial stability with a slight decrease in its equity ratio. The forecast for the fiscal year ending June 20, 2025, anticipates continued growth with a 9.3% increase in net sales and a 10.7% rise in net income, indicating positive momentum for stakeholders.
More about Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. operates in the retail industry, primarily focusing on the sale of pharmaceuticals and health-related products. The company is listed on the Tokyo Stock Exchange and is known for its extensive network of drugstores across Japan.
YTD Price Performance: 7.84%
Average Trading Volume: 49,275
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen103.4B
See more insights into 9267 stock on TipRanks’ Stock Analysis page.